Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 240

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 240
---
 Shares in Taiwan.

Notice to Prospective Investors in United Arab Emirates

The Class A Ordinary Shares have not been offered
or sold, and will not be offered or sold, directly or indirectly, in the United Arab Emirates, except: (i) in compliance with all
applicable laws and regulations of the United Arab Emirates; and (ii) through persons or corporate entities authorized and licensed
to provide investment advice and/or engage in brokerage activity and/or trade in respect of foreign securities in the United Arab Emirates.
The information contained in this prospectus does not constitute a public offer of securities in the United Arab Emirates in accordance
with the Commercial Companies Law (Federal Law No. 8 of 1984 (as amended)) or otherwise and is not intended to be a public offer
and is addressed only to persons who are sophisticated investors.

Notice to Prospective Investors in United Kingdom

This prospectus is only being distributed to and
is only directed at: (i) persons who are outside the United Kingdom; (ii) investment professionals falling within Article 19(5) of
the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, or the Order; or (iii) high net worth companies,
and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such
persons falling within (i)-(iii) together being referred to as “relevant persons”). The Class A Ordinary Shares are only
available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire the Class A Ordinary Shares will be engaged
in only with, relevant persons. Any person who is not a relevant person should not act or rely on this prospectus or any of its contents.

<div align='center'>136

EXPENSES RELATING TO THIS OFFERING</div>

Set forth below is an itemization of the total
expenses, excluding underwriting discounts, that Living Homeopathy expects to incur in connection with this Offering. With the exception
of the SEC registration fee and the Nasdaq Capital Market listing fee, all amounts are estimates.

|                                    |     | $ |
| Securities and Exchange Commission 
 Registration Fee                   |     | $ |
| FINRA Filing Fee                   |     | $ |
| Nasdaq Capital Market Listing Fee  |     | $ |
| Legal Fees and Expenses            |     | $ |
| Accounting Fees and Expenses       |     | $ |
| Transfer Agent Fees                |